Replimune Group Inc buy BMO Capital Markets
Start price
30.06.26
/
50%
€10.65
Target price
30.06.27
€14.04
Performance (%)
-8.92%
Price
30.07.26
€4.64
Summary
This prediction is currently active. With a performance of -8.92%, the BUY prediction for Replimune Group Inc by BMO_Capital_Markets is down slightly. This prediction currently runs until 30.06.27. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Replimune Group Inc | -49.444% | -49.444% |
| iShares Core DAX® | 2.591% | 2.691% |
| iShares Nasdaq 100 | -0.915% | -7.368% |
| iShares Nikkei 225® | 0.145% | -10.196% |
| iShares S&P 500 | -0.367% | -0.833% |
Comments by BMO_Capital_Markets for this prediction
In the thread Replimune Group Inc diskutieren
Replimune Group (REPL) was upgraded by BMO Capital Markets from "underperform" to "outperform". They now have a $16.00 price target on the stock.
Ratings data for REPL provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Replimune Group Inc
Replimune Group Inc
Start price
Target price
Perf. (%)
€1.51
13.04.26
13.04.26
€0.86
13.04.27
13.04.27
544.09%
30.07.26
30.07.26
Replimune Group Inc
Start price
Target price
Perf. (%)
€2.40
23.07.25
23.07.25
€1.70
23.07.26
23.07.26
275.67%
24.07.26
24.07.26
Replimune Group Inc
Start price
Target price
Perf. (%)
€12.90
22.01.25
22.01.25
€25.92
22.01.26
22.01.26
-48.84%
23.01.26
23.01.26
Replimune Group Inc
Start price
Target price
Perf. (%)
€15.40
22.11.24
22.11.24
€17.31
22.11.25
22.11.25
-49.03%
23.11.25
23.11.25